Biopharmas raising money in public or private financings, including: Apellis, Aprea, Contrafect, Oricell, Travere, Verismo.

New hires and promotions in the biopharma industry, including: Argenx, Enveric, Frontier Medicines, Korro, Longeveron, Sutro.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apyx Medical, Lucira Health, Milestone Scientific.

Med-tech firms raising money in public or private financings, including: Visionhealth.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: GE Healthcare, Iradimed, Macrogen, Monopar Therapeutics, Northstar Medical Radioisotopes, Orthoventions, Singleron, Sonde, Sonothera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Conformal Medical, Medtronic.

New hires and promotions in the med-tech industry, including: Diagnostix, Saranas.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akebia, Astrazeneca, Beigene, Chiesi, Daiichi Sankyo, Incyte, Janssen, Merck, Protalix, Regeneron, Ridgeback, Servier, Sobi, Timber.